High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey

Institutions:

• Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
• Department of Hematology and Oncology, Okinawa Chubu Hospital, Uruma, Japan
• Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
• Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
• Department of Hematology and Oncology, Niigata Cancer Center Hospital, Niigata, Japan
• Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan
• Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
• Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan
• Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan
• Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan